Shoulder Innovations, Inc. (SI) stock
SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3051% above fair value
$20.65+0.09 (+0.44%)
Close on Nov 18, 2026Market cap $429.91MP/E –Yield –
Shoulder Innovations operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Shoulder Innovations's operating income for the twelve months ending Jun 30, 2026 was -$35.15M. For fiscal 2025 it was -$26.30M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$26.30M | – |
| FY2024 | Dec 31, 2024 | -$14.65M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$10.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.98M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.64M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.86M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.29M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.54M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.88M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.98M | – |
See a number that looks wrong?